- Home
- XENE vs SID Comparison
XENE vs SID Comparison
Compare XENE & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- SID
- Stock Information
- Founded
- XENE 1996
- SID 1941
- Country
- XENE Canada
- SID Brazil
- Employees
- XENE N/A
- SID N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- SID Steel/Iron Ore
- Sector
- XENE Health Care
- SID Industrials
- Exchange
- XENE Nasdaq
- SID Nasdaq
- Market Cap
- XENE 2.3B
- SID 1.9B
- IPO Year
- XENE 2014
- SID 1997
- Fundamental
- Price
- XENE $32.05
- SID $1.44
- Analyst Decision
- XENE Strong Buy
- SID Strong Sell
- Analyst Count
- XENE 11
- SID 1
- Target Price
- XENE $54.82
- SID $1.30
- AVG Volume (30 Days)
- XENE 977.8K
- SID 3.3M
- Earning Date
- XENE 08-07-2025
- SID 08-11-2025
- Dividend Yield
- XENE N/A
- SID 15.99%
- EPS Growth
- XENE N/A
- SID N/A
- EPS
- XENE N/A
- SID N/A
- Revenue
- XENE $7,500,000.00
- SID $7,828,045,151.00
- Revenue This Year
- XENE N/A
- SID $7.14
- Revenue Next Year
- XENE $253.71
- SID $3.79
- P/E Ratio
- XENE N/A
- SID N/A
- Revenue Growth
- XENE N/A
- SID 2.40
- 52 Week Low
- XENE $26.74
- SID $1.27
- 52 Week High
- XENE $46.00
- SID $2.50
- Technical
- Relative Strength Index (RSI)
- XENE 51.34
- SID 40.77
- Support Level
- XENE $31.22
- SID $1.45
- Resistance Level
- XENE $33.46
- SID $1.56
- Average True Range (ATR)
- XENE 1.28
- SID 0.05
- MACD
- XENE 0.27
- SID -0.00
- Stochastic Oscillator
- XENE 68.60
- SID 3.57
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.